FASLG and neoplasm: The TME further supports effector T cell exclusion from the tumor by hindering the expression of adhesion molecules, such as ICAM-1 and VCAM-1, and inducing the expression of immunosuppressive molecules, such as FasL and PD-L1, at the surface of tumor-associated BECs [103,104].